SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Munch-a-Biotech Today
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tommysdad who wrote (469)6/25/1999 2:10:00 AM
From: Spekulatius   of 3158
 
I do not see Genzyme as an acquisition candidate for a big drug company. Genzyme has a very successful niche strategy.It has unique product without competition which means there would not be much synergy. Thats why I do not believe a merger will happen.
The pharma companies will more likely buy companies with products fitting into their own portfolio and which can be sold through their own salesforce.
If anything, Genzyme should be on the acquisition side itself.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News